Current Report Filing (8-k)
May 26 2017 - 4:42PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 25, 2017
MEDICAL PROPERTIES TRUST, INC.
(Exact Name of Registrant as Specified in Charter)
Commission
File Number 001-32559
|
|
|
Maryland
|
|
20-0191742
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I. R. S. Employer
Identification No.)
|
|
|
1000 Urban Center Drive, Suite 501
Birmingham, AL
|
|
35242
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code
(205) 969-3755
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Section 5. Corporate Governance and Management.
Item 5.07.
|
Submission of Matters to a Vote of Security Holders
|
Our annual meeting of stockholders was held on
May 25, 2017. The four proposals considered at the annual meeting were voted on as follows:
Proposal 1
: The election of seven directors for
the ensuing year. The number of votes cast for and against for each nominee for director along with the number of abstentions and broker non-votes is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominee:
|
|
For:
|
|
|
Against:
|
|
|
Abstentions and
Broker
Non-Votes:
|
|
Edward K. Aldag, Jr.
|
|
|
240,535,094
|
|
|
|
6,290,611
|
|
|
|
52,690,052
|
|
G. Steven Dawson
|
|
|
240,788,819
|
|
|
|
6,025,088
|
|
|
|
52,701,850
|
|
R. Steven Hamner
|
|
|
224,083,922
|
|
|
|
22,731,675
|
|
|
|
52,700,160
|
|
William G. McKenzie
|
|
|
183,848,108
|
|
|
|
62,960,056
|
|
|
|
52,707,593
|
|
D. Paul Sparks, Jr.
|
|
|
245,528,073
|
|
|
|
1,277,100
|
|
|
|
52,710,584
|
|
Michael G. Stewart
|
|
|
245,086,311
|
|
|
|
1,724,833
|
|
|
|
52,704,613
|
|
C. Reynolds Thompson, III
|
|
|
242,127,550
|
|
|
|
4,679,580
|
|
|
|
52,708,627
|
|
Proposal 2
: A proposal to ratify the appointment of PricewaterhouseCoopers LLP as independent registered public
accounting firm for the fiscal year ending December 31, 2017. The number of votes that were cast for and against this proposal and the number of abstentions are set forth below:
|
|
|
|
|
For:
|
|
Against:
|
|
Abstentions:
|
294,629,872
|
|
3,932,547
|
|
953,338
|
Proposal 3
: A proposal for an advisory resolution regarding executive compensation. The number of votes that were cast
for and against this proposal and the number of abstentions and broker non-votes are set forth below:
|
|
|
|
|
For:
|
|
Against:
|
|
Abstentions and
Broker Non-Votes:
|
231,356,060
|
|
14,787,831
|
|
53,371,866
|
Proposal 4
: A proposal for an advisory resolution regarding the frequency of future advisory votes on executive officer
compensation. The number of votes that were cast to conduct future votes on executive compensation for every 1-year, 2-years, 3-years or abstentions and broker non-votes are set forth below:
|
|
|
|
|
|
|
1-year:
|
|
2-years:
|
|
3-years:
|
|
Abstentions and
Broker Non-Votes:
|
212,687,701
|
|
1,509,712
|
|
32,275,450
|
|
53,042,894
|
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
MEDICAL PROPERTIES TRUST, INC.
|
(Registrant)
|
|
|
By:
|
|
/s/ R. Steven Hamner
|
|
|
R. Steven Hamner
|
|
|
Executive Vice President and Chief Financial Officer
|
|
Date: May 26, 2017
|
Medical Properties (NYSE:MPW)
Historical Stock Chart
From Apr 2024 to May 2024
Medical Properties (NYSE:MPW)
Historical Stock Chart
From May 2023 to May 2024